149 Furthermore, daily aspirin use in combination with PD-L1 inhibitors in NSCLC patients showed a trend toward improved complete remission rates and significantly reduced the likelihood of progressive disease, suggesting that aspirin could enhance outcomes in combination with PD-L1 inhibitors. 150 Interestingly, aspirin exhibits a dual role in cancer cell proliferation.
1
—
—